186 related articles for article (PubMed ID: 12920206)
1. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression.
Chabut D; Fischer AM; Colliec-Jouault S; Laurendeau I; Matou S; Le Bonniec B; Helley D
Mol Pharmacol; 2003 Sep; 64(3):696-702. PubMed ID: 12920206
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells.
Zemani F; Benisvy D; Galy-Fauroux I; Lokajczyk A; Colliec-Jouault S; Uzan G; Fischer AM; Boisson-Vidal C
Biochem Pharmacol; 2005 Oct; 70(8):1167-75. PubMed ID: 16153611
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of alpha6 integrin in endothelial cells unveils a proangiogenic role for basement membrane.
Primo L; Seano G; Roca C; Maione F; Gagliardi PA; Sessa R; Martinelli M; Giraudo E; di Blasio L; Bussolino F
Cancer Res; 2010 Jul; 70(14):5759-69. PubMed ID: 20570893
[TBL] [Abstract][Full Text] [Related]
4. Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis.
Durand E; Helley D; Al Haj Zen A; Dujols C; Bruneval P; Colliec-Jouault S; Fischer AM; Lafont A
J Vasc Res; 2008; 45(6):529-37. PubMed ID: 18463418
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
[TBL] [Abstract][Full Text] [Related]
6. Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro.
Matou S; Helley D; Chabut D; Bros A; Fischer AM
Thromb Res; 2002 May; 106(4-5):213-21. PubMed ID: 12297128
[TBL] [Abstract][Full Text] [Related]
7. Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro.
Matou S; Colliec-Jouault S; Galy-Fauroux I; Ratiskol J; Sinquin C; Guezennec J; Fischer AM; Helley D
Biochem Pharmacol; 2005 Mar; 69(5):751-9. PubMed ID: 15710353
[TBL] [Abstract][Full Text] [Related]
8. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor regulates expression of heparan sulfate in human periodontal ligament cells.
Shimabukuro Y; Ichikawa T; Terashima Y; Iwayama T; Oohara H; Kajikawa T; Kobayashi R; Terashima H; Takedachi M; Terakura M; Hashikawa T; Yamada S; Murakami S
Matrix Biol; 2008 Apr; 27(3):232-41. PubMed ID: 18036796
[TBL] [Abstract][Full Text] [Related]
10. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
Delehedde M; Deudon E; Boilly B; Hondermarck H
Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
[TBL] [Abstract][Full Text] [Related]
12. Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.
Khorana AA; Sahni A; Altland OD; Francis CW
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2110-5. PubMed ID: 12920044
[TBL] [Abstract][Full Text] [Related]
13. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
14. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro.
Collen A; Smorenburg SM; Peters E; Lupu F; Koolwijk P; Van Noorden C; van Hinsbergh VW
Cancer Res; 2000 Nov; 60(21):6196-200. PubMed ID: 11085545
[TBL] [Abstract][Full Text] [Related]
15. alpha6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells.
Bouvard C; Gafsou B; Dizier B; Galy-Fauroux I; Lokajczyk A; Boisson-Vidal C; Fischer AM; Helley D
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1569-75. PubMed ID: 20508204
[TBL] [Abstract][Full Text] [Related]
16. Sulfated polysaccharides are required for collagen-induced vascular tube formation.
Jackson CJ; Giles I; Knop A; Nethery A; Schrieber L
Exp Cell Res; 1994 Dec; 215(2):294-302. PubMed ID: 7526991
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
[TBL] [Abstract][Full Text] [Related]
18. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
[TBL] [Abstract][Full Text] [Related]
19. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
